Cardiopulmonary bypass strategy without donor blood components as a method for preventing brain damage in children
https://doi.org/10.17802/2306-1278-2021-10-2S-21-26
Abstract
Aim. To establish the role of donor blood components which are used in the intraoperative period in children with septal congenital heart disease (CHD) who need surgical interventions with cardiopulmonary bypass (CPB) for the prevention of cerebral injury in the postoperative period.
Methods. 40 children of 14 months old on average and 8.8 kg of weight were under the study. All patients underwent radical correction of the septal CHD with the use of CPB. The patients were divided into 2 groups according to the donated blood components used. Cerebral damage was assessed with the help of three specific markers: protein S-100-ß, neuron-specific enolase (NSE) and glial fibrillar acidic protein (GFAP). The severity of the systemic inflammatory response was defined by the level of the following markers: interleukin 1, 6 and 10 in serum before operations, after the completion of IC and 16 hours after surgery. The clinical analysis of cerebral injury was performed via the Cornell Assessment for Pediatric Delirium.
Results. Statistically the concentration of all three markers of cerebral injury was significantly higher in the transfusion group after the end of CPB. Similar dynamics was observed in the concentrations of interleukins. In addition, the values for GFAP were higher in the transfusion group and 16 hours after surgery.
Conclusion. The safety and effectiveness of the strategy on refusal of intraoperative transfusion in order to prevent cerebral injury in children during the correction of septal CHD has been demonstrated.
About the Authors
A. A. IvkinRussian Federation
junior research assistant at the Laboratory of Anesthesiology, Intensive Care and Pathophysiology of Critical Conditions, Department of Heart and Vascular Surgery,
6, Sosnoviy Blvd., Kemerovo, 650002
D. V. Borisenko
Russian Federation
anesthesiologist-resuscitator at the Intensive Care Unit,
6, Sosnoviy Blvd., Kemerovo, 650002
E. V. Grigoriev
Russian Federation
PhD, Professor of the Russian Academy of Sciences, Deputy Director for Scientific and Medical Issues,
6, Sosnoviy Blvd., Kemerovo, 650002
References
1. Boehne M., Sasse M., Karch A., Dziuba F., Horke A., Kaussen T., Mikolajczyk R., Beerbaum P., Jack T. Systemic inflammatory response syndrome after pediatric congenital heart surgery: Incidence, risk factors, and clinical outcome. Journal of cardiac surgery. 2017;32(2):116-125. doi: 10.1111/jocs.12879.
2. Wang Y., Lin X., Yue H., Kissoon N., Sun B.; Collaborative Study Group for Pediatric Sepsis in Huai’an. Evaluation of systemic inflammatory response syndrome-negative sepsis from a Chinese regional pediatric network..BMC Pediatr. 2019; 8; 19 (1): 11. doi: 10.1186/s12887-018-1364-8.
3. Ivkin A.A., Kornelyuk R.A., Borisenko D.V., Nohrin A.V., Shukevich D.L. Cardiopulmonary bypass without the use of donor blood components in heart surgery in an 8-kg infant: case report. Patologiya krovoobrashcheniya i kardiokhirurgiya = Circulation Pathology and Cardiac Surgery. 2018;22(2):63- 67. (In Russ.). http://dx.doi.org/10.21688/1681-3472-2018-2- 63-67
4. Delaney M., Stark P.C., Suh M., Triulzi D.J., Hess J.R., Steiner M.E., Stowell C.P., Sloan S.R. Massive Transfusion in Cardiac Surgery: The Impact of Blood Component Ratios on Clinical Outcomes and Survival. Anesthesia and Analgesia. 2017; 124(6): 1777-1782. doi: 10.1213/ANE.0000000000001926
5. Hirata Y. Cardiopulmonary bypass for pediatric cardiac surgery. General Thoracic and Cardiovascular Surgery. 2018; 66 (2): 65-70. doi: 10.1007/s11748-017-0870-1.
6. Narkevich A.N., Vinogradov K.A. Methods for determining the minimum required sample size in medical research. Social'nye aspekty zdorov'a naselenia / Social aspects of population health [serial online] 2019; 65(6):10. Available from: http://vestnik.mednet.ru/content/view/1123/30/lang,ru/. (In Rus). DOI: 10.21045/2071-5021-2019-65-6-10
7. Lasek-Bal A., Jedrzejowska-Szypulka H., Student S., Warsz-Wianecka A., Zareba K., Puz P., Bal W., Pawletko K., Lewin-Kowalik J. The importance of selected markers of inflammation and blood-brain barrier damage for shortterm ischemic stroke prognosis. Journal of Physiology and Pharmacology. 2019; 70(2). doi: 10.26402/jpp.2019.2.04.
8. Silver G., Kearney J., Traube C., Hertzig M. Delirium screening anchored in child development: The Cornell Assessment for Pediatric Delirium. Palliat Support Care. 2015;13(4):1005-11. doi: 10.1017/S1478951514000947.
Review
For citations:
Ivkin A.A., Borisenko D.V., Grigoriev E.V. Cardiopulmonary bypass strategy without donor blood components as a method for preventing brain damage in children. Complex Issues of Cardiovascular Diseases. 2021;10(2):21-26. (In Russ.) https://doi.org/10.17802/2306-1278-2021-10-2S-21-26